Patents by Inventor Gavin Welsh

Gavin Welsh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AAV gene therapy vector with podocyte-specific promoter
    Patent number: 12589167
    Abstract: A viral vector, wherein the viral vector comprises a COL4A3, COL4A4 or COL4A5 transgene.
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: March 31, 2026
    Assignees: The University of Bristol, Syncona IP Holdco (3) Limited
    Inventors: Dominic Schmidt, Valeryia Kuzmuk, Moin Saleem, Gavin Welsh
  • MINIMAL NEPHRIN PROMOTER
    Publication number: 20250283072
    Abstract: A promoter comprising (i) a nucleotide sequence having at least 70% identity to SEQ ID NO: 4 or 17 and wherein the promoter has a length of about 1.1 kb or less.
    Type: Application
    Filed: March 14, 2022
    Publication date: September 11, 2025
    Inventors: Moin Saleem-Uddin, Gavin Welsh, Valeryia Kuzmuk, Alan William Griffith
  • GENE THERAPY
    Publication number: 20240197917
    Abstract: A viral vector, wherein the viral vector comprises a COL4A3, COL4A4 or COL4A5 transgene.
    Type: Application
    Filed: March 12, 2021
    Publication date: June 20, 2024
    Inventors: Dominic Schmidt, Valeryia Kuzmuk, Moin Saleem, Gavin Welsh